United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 30, 2026 · Filed Jul 31, 2026

On Jul 30, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$524.90 for US$4.99M under a trading plan, leaving 324,443 shares. Filed Jul 31, 2026 (Form 4).

Sold
9,500 shares
Price
US$524.90 average (US$523.04 to US$528.96)
Value
US$4.99M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 30, 2026Common StockSale644US$523.04333,299Indirect
Jul 30, 2026Common StockSale1,486US$523.87331,813Indirect
Jul 30, 2026Common StockSale4,846US$524.88326,967Indirect
Jul 30, 2026Common StockSale2,084US$525.80324,883Indirect
Jul 30, 2026Common StockSale400US$526.92324,483Indirect
Jul 30, 2026Common StockSale40US$528.96324,443Indirect

Source

View original at SEC

Related